|
The Endowed Scholars Program in Biomedical Research provides start-up research support for newly appointed, tenure-track assistant professors. Individuals who already hold tenure-track faculty positions at UT Southwestern or elsewhere are not eligible.
Essential features of the program are:
- In excess of $1,000,000 over four years is provided to support the independent research activities ($700,000), partial salary, and fringe benefits of each newly appointed assistant professor.
- Five scholars will be appointed each year.
- Positions in both Basic Science and Clinical Science departments are available.
- The primary responsibility of the scholars will be research. Teaching and some clinical duties (if appropriate) will also be included.
- Research space and additional funding for salary will be provided by the medical school department or research center offering the appointment.
- Scholars will be nominated by chairs and directors of the Medical Center’s basic and clinical academic departments and research centers. Final selections will be made by an Endowed Scholar Committee consisting of Dr. Eric N. Olson (Chair), Drs. Johann Deisenhofer, Joseph Goldstein, Helen Hobbs, David Mangelsdorf, Luis Parada, and Michael Rosen.
- Applications will be reviewed after two annual deadlines—December 1st and February 1st. Applications will be considered at other times under unusual circumstances.
- Scholars are eligible to join any of the interdisciplinary graduate training faculties of the University of Texas Southwestern Graduate School of Biomedical Sciences.
- UT Southwestern's 12 Core Facilites are available with the latest equipment and knowledge necessary to assist Scholars in their work.
- Scholars will compete for extramural research funding as their research programs become established.
- Scholars and the progress of the program are evaluated biannually by an External Advisory Committee (Stanley Prusiner, UCSF [Chair]; Bruce Alberts, University of California, San Francisco; Richard Axel, Columbia University; Marc Kirschner, Harvard; Titia de Lange, Rockefeller University; Stuart Orkin, Harvard Medical School).
|
